OXYBUTYNIN CHLORIDE
Generic: OXYBUTYNIN CHLORIDE
Ajanta Pharma USA Inc.Manufacturer
ORALRoute
OXYBUTYNIN CHLORIDEActive Substance
2019-02-28Original Approval
OXYBUTYNIN CHLORIDE is FDA application ANDA211655, sponsored by AJANTA PHARMA LTD. Any recalls listed below come from FDA drug enforcement reports, and reaction counts are the number of FAERS adverse event reports that mention the drug and that reaction; a report does not prove the drug caused it.
Recalls
Class II2018-12-11
Oxybutynin Chloride Tablets, USP, 5 mg, 500-count bottle, Rx only, Mfd. By: KVK-Tech, Inc., Newtown, PA 18940, NDC 10702Labeling: Wrong bar code
Class III2019-03-01
Oxybutynin Chloride Extended-Release Tablets USP 10 mg, a) 100 tablets (NDC 42291-634-01) and b) 500 tablets (NDC 42291-Failed Dissolution Specifications
Class III2019-02-21
Oxybutynin Chloride, Extended-Release Tablets USP, 10 mg, 100 Tablet, Rx Only, Distributed by: Lannett Company, Inc, PhiFailed Dissolution Specifications
Top Reported Reactions
1
FATIGUE
744 reports
2
DRUG INEFFECTIVE
704 reports
3
NAUSEA
619 reports
4
FALL
589 reports
5
HEADACHE
571 reports
6
DIARRHOEA
518 reports
7
PAIN
493 reports
8
URINARY TRACT INFECTION
454 reports
9
DIZZINESS
448 reports
10
CONSTIPATION
407 reports